Genetic
and
non-genetic
factors
are
responsible
for
the
high
interindividual
variability
in
response
to
SARS-CoV-2.
Although
numerous
genetic
polymorphisms
have
been
identified
as
risk
severe
COVID-19,
these
remain
understudied
Latin-American
populations.
This
study
evaluated
association
of
three
polymorphisms:
Scientific Reports,
Год журнала:
2022,
Номер
12(1)
Опубликована: Фев. 10, 2022
Abstract
Chronic
kidney
disease
(CKD)
has
been
recognized
as
a
highly
prevalent
risk
factor
for
both
the
severity
of
coronavirus
2019
(COVID-19)
and
COVID-19
associated
adverse
outcomes.
In
this
multicenter
observational
cohort
study,
we
aim
to
determine
mortality
readmission
rates
patients
hospitalized
across
varying
CKD
stages.
We
performed
study
among
included
in
Dutch
COVIDPredict
cohort.
The
consists
from
March
2020
until
July
2021
with
PCR-confirmed
SARS-CoV-2
infection
or
suspected
CT
scan-based
CORADS
score
≥
4.
A
total
4151
were
who
389
had
history
before
admission.
After
adjusting
all
confounding
covariables,
stage
3a,
3b,
4
KTX
(kidney
transplantation),
odds
ratios
death
compared
without
ranged
1.96
8.94.
demonstrate
an
evident
increased
12-week
rate
chronic
disease.
Besides
justified
concerns
transplant
patients,
clinicians
should
also
be
aware
more
severe
outcomes
vulnerability
patients.
Infectious
diseases
have
shaped
the
human
population
genetic
structure,
and
variation
influences
susceptibility
to
many
viral
diseases.
However,
a
variety
of
challenges
made
implementation
traditional
Genome-wide
Association
Studies
(GWAS)
approaches
study
these
infectious
outcomes
challenging.
In
contrast,
mouse
models
provide
an
experimental
control
precision,
which
facilitates
analyses
mechanistic
studies
role
on
infection.
Here
we
use
mapping
cross
between
two
distinct
Collaborative
Cross
strains
with
respect
severe
acute
respiratory
syndrome
coronavirus
(SARS-CoV)
disease
outcomes.
We
find
several
loci
differential
outcome
for
traits
in
context
SARS-CoV
Importantly,
identify
locus
chromosome
9
that
shows
conserved
synteny
GWAS
SARS-CoV-2
disease.
follow-up
confirm
this
locus,
candidate
genes,
CCR9
CXCR6,
both
play
key
regulating
severity
SARS-CoV,
SARS-CoV-2,
distantly
related
bat
sarbecovirus
As
such
template
using
crosses
characterize
multitrait
regulate
pathogenic
across
species.
IMPORTANCE
Host
is
important
determinant
predicts
following
setting
highly
infections
determinants
underlying
host
mortality
remain
unclear.
To
elucidate
pathogenesis
outcomes,
utilized
(CC)
reference
as
model
alleles
infections.
Our
findings
reveal
found
regulator
mice.
Within
identified
validated
CXCR6
regulators
Specifically,
are
protective
against
SARS-related
HKU3
virus
This
may
be
help
genes
humans.
BMC Medical Genomics,
Год журнала:
2024,
Номер
17(1)
Опубликована: Май 23, 2024
Abstract
The
symptoms
of
SARS-CoV-2
infection
vary
widely,
ranging
from
asymptomatic
cases
to
severe
forms
marked
by
acute
respiratory
distress
syndrome,
multi-organ
damage,
and
fatalities.
Studies
indicate
a
correlation
between
specific
genes
susceptibility
disease
severity,
particularly
involving
variants
in
linked
inflammation
immune
responses.
objective
this
study
is
investigate
the
association
rs1800795
(−
174
G
>
C)
rs1800797
597
A
G)
interleukin-6
(IL-6)
promoter
region
infection.
Additionally,
we
aim
explore
their
with
COVID-19
severity
Moroccan
population.
In
case-control
study,
enrolled
270
unvaccinated
patients,
consisting
132
138
asymptomatic-moderate
COVID-19.
included
339
SARS-CoV-2-negative
group.
Genotyping
polymorphisms
IL-6
gene
was
performed
using
predesigned
TaqMan
SNP
genotyping.
median
age
controls
50
years,
while
exhibited
61
years.
individuals
moderate
had
36
We
observed
significant
difference
mild
patients
(
p
<
0.0001),
an
noted
gender
=
0.011).
allele
genotype
frequencies
−
597G
174G
C
did
not
show
associations
0.05).
However,
further
analysis
revealed
that
linkage
disequilibrium
indicated
GC*
haplotype
(OR
0.04,
95%
CI
0.01–0.30,
0.001)
AG*
0.11,
0.03–0.46,
0.002)
were
significantly
associated
protection
against
Moreover,
overdominant
model,
G/C
found
be
protective
development
compared
those
G/G-C/C
genotypes
0.03;
OR
0.41,
0.18–0.96).
correlations
complete
blood
count
markers,
hematological
D-dimer,
C-reactive
protein,
ferritin
levels
according
showed
no
differences
(all
Our
findings
provide
valuable
insights
into
pathogenesis
COVID-19,
suggesting
genetic
variations
at
may
contribute
within
ESMO Open,
Год журнала:
2022,
Номер
7(3), С. 100499 - 100499
Опубликована: Май 8, 2022
ESMO
COVID-19
and
CAncer
REgistry
(ESMO-CoCARE)
is
an
international
collaborative
registry-based,
cohort
study
gathering
real-world
data
from
Europe,
Asia/Oceania
Africa
on
the
natural
history,
management
outcomes
of
patients
with
cancer
infected
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2).
Genetic
and
non-genetic
factors
are
responsible
for
the
high
interindividual
variability
in
response
to
SARS-CoV-2.
Although
numerous
genetic
polymorphisms
have
been
identified
as
risk
severe
COVID-19,
these
remain
understudied
Latin-American
populations.
This
study
evaluated
association
of
three
polymorphisms: